The Management of Bosnalijek company has decided that the profit realized in 2016 of the amount of nearly nine million BAM will be split in two ways. For the dividend payment, the company will give 4.4 million BAM and the rest of 5 million BAM will be spent for the improvement and further development of this pharmaceutical company’s business.
Dividends will be paid to shareholders who, at the date of adoption of the Decision, are registered as shareholders of the Company at the Securities Registry in the Federation of Bosnia and Herzegovina.
(Source: akta)
